A case of an acute cutaneous drug reaction with hydroxychloroquine

Scott Med J. 2018 Aug;63(3):91-94. doi: 10.1177/0036933018763277. Epub 2018 Mar 7.

Abstract

Hydroxychloroquine is considered a relatively benign drug and is regularly used by rheumatologists and dermatologists. We highlight the severe adverse drug reaction potential of this commonly prescribed medication. We report the case of a 63-year-old male, who presented with widespread skin eruption following initiation of hydroxychloroquine two weeks earlier for an inflammatory arthritis. He had typical clinical, biochemical and histological features of the now recognised formal 'diagnosis' of severe cutaneous adverse drug reaction. The culprit drug was stopped and he responded to oral and topical steroids as well as supportive measures. Severe reactions to hydroxychloroquine are uncommon; however, as in this case, drug hypersensitivity reactions often manifest in skin. In a drug normally considered to be safe, these potential cutaneous side effects should be highlighted in information given to patients prior to commencement.

Keywords: Hydroxychloroquine; drug rash with eosinophilia and systemic symptoms; severe cutaneous adverse drug reactions.

Publication types

  • Case Reports

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Anti-Inflammatory Agents / therapeutic use
  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / adverse effects*
  • Drug Eruptions / drug therapy
  • Drug Eruptions / pathology*
  • Humans
  • Hydroxychloroquine / administration & dosage
  • Hydroxychloroquine / adverse effects*
  • Male
  • Middle Aged
  • Mometasone Furoate / therapeutic use
  • Prednisolone / therapeutic use
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Antirheumatic Agents
  • Mometasone Furoate
  • Hydroxychloroquine
  • Prednisolone